Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 149   

Articles published

BMY 53.63 +1.13 (2.15%)
price chart
Watch List Highlights - Bristol-Myers Squibb Co (NYSE:BMY), Moody's ...
Bristol-Myers Squibb Co (NYSE:BMY) reported Q3 adjusted EPS of $0.45, three cents better than the analyst consensus on Capital IQ.
Bristol-Myers Squibb Co's Third-Quarter Earnings Beat the Street  Motley Fool
Market Update: Bristol-Myers Squibb Company (NYSE:BMY) - Bristol-Myers ...  Jutia Group
Related articles »  
Stocks to Watch: Bristol-Myers Squibb Company (NYSE:BMY), TriQuint ...
Bristol-Myers Squibb (NYSE:BMY) will release its Q3 2014 results on October 24th. We expect strong performance from its key drugs Eliquis and Yervoy.
Related articles »  
Today's Premarket Earnings: Bristol-Myers Squibb Co, Colgate-Palmolive ...
Bristol-Myers Squibb Co (BMY ) reported third quarter earnings of $721 million, or 43 cents per share, up from $692 million, or 42 cents per share a year ago.
Bristol-Myers Squibb Q3 Earnings Top Estimates
However, the company affirmed its adjusted earnings forecast of $1.70 to $1.80 per share. It also projects 2014 revenue of $15.2 billion to $15.8 billion, versus analysts' estimates of $15.59 billion.
Bristol-Myers Squibb Q3 Profit Rises, Adj. EPS Tops View
(RTTNews.com) - Drugmaker Bristol-Myers Squibb Co. ( BMY ) Friday said third-quarter profit increased from the previous year, even as revenues declined due to the divested Diabetes alliance.
Bristol-Myers Squibb Q3 Profit Tops View - Quick Facts
Drugmaker Bristol-Myers Squibb Co. (BMY: Quote) Friday said third-quarter net earnings attributable to the company grew to $721 million from $692 million in the previous year.
Stocks in Focus- Bristol-Myers Squibb Co (NYSE:BMY), Novartis AG (ADR ...
AstraZeneca Plc and Bristol-Myers Squibb Co (NYSE:BMY) won an appeal of an 11 year old lawsuit in which they were suspect of paying kickbacks to a medical benefits management company in return for purchases and approvals of drugs they make.
Morning Buzz: Petroleo Brasileiro (NYSE:PBR-A), AstraZeneca (NYSE:AZN ...  WallStreet Scope
Related articles »  
Bristol-Myers Squibb Reports Third Quarter 2014 Financial Results
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today reported strong financial results for the third quarter of 2014, adjusted 2014 GAAP guidance and confirmed 2014 non-GAAP guidance.
Healthcare Stocks in Focus - Bristol-Myers Squibb Co (NYSE:BMY), Shire Plc ...
Bristol-Myers Squibb Co (NYSE:BMY) tossed up 2.5% on Friday after the healthcare stock declared higher than predicted third-quarter earnings, as positive sales of its treatments for blood clots, cancer and arthritis assisted in hiding impact of sharply ...
Related articles »  
Investors Watch List : ARRIS Group, Inc. (NASDAQ:ARRS), Bristol-Myers Squibb ...
Bristol-Myers Squibb Company (NYSE:BMY) is scheduled to report its third-quarter 2014 results on Oct 24, before the opening bell.